{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:59:39Z","timestamp":1777363179710,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.dld.2025.04.001","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:48:30Z","timestamp":1747122510000},"page":"1455-1464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dietary lipophilic index and odds of metabolic dysfunction-associated steatotic liver disease (MASLD): A population-based study"],"prefix":"10.1016","volume":"57","author":[{"given":"Safoora","family":"Hedayati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Doustmohammadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Jambarsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansooreh","family":"Maadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdieh","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2025.04.001_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.dld.2025.04.001_bib0003","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.dld.2025.04.001_bib0004","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.dld.2025.04.001_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.dld.2025.04.001_bib0006","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2004.00126.x","article-title":"Hepatic steatosis in obese patients: clinical aspects and prognostic significance","volume":"5","author":"Festi","year":"2004","journal-title":"Obesity Rev"},{"key":"10.1016\/j.dld.2025.04.001_bib0008","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","article-title":"Nonalcoholic fatty liver disease: a review and update","volume":"55","author":"Lewis","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"28","key":"10.1016\/j.dld.2025.04.001_bib0009","first-page":"9338","article-title":"Role of diet and lifestyle changes in nonalcoholic fatty liver disease","volume":"20","author":"Nseir","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"issue":"4","key":"10.1016\/j.dld.2025.04.001_bib0010","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Dierkhising RA Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2025.04.001_bib0011","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.04.001_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"issue":"16","key":"10.1016\/j.dld.2025.04.001_bib0013","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4155\/fmc-2019-0003","article-title":"Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease","volume":"11","author":"Ballestri","year":"2019","journal-title":"Future Med Chem"},{"issue":"4","key":"10.1016\/j.dld.2025.04.001_bib0014","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004836-200304000-00015","article-title":"Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study","volume":"36","author":"S\u00f8rensen","year":"2003","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2017.09.012","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","volume":"68","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.dld.2025.04.001_bib0016","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.dld.2025.04.001_bib0017","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.dld.2025.04.001_bib0018","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/eurheartj\/ehr453","article-title":"Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?","volume":"33","author":"Bhatia","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.dld.2025.04.001_bib0019","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.21768","article-title":"Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future","volume":"46","author":"Wieckowska","year":"2007","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.dld.2025.04.001_bib0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.04.001_bib0021","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2025.04.001_bib0022","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4254\/wjh.v4.i7.209","article-title":"Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease","volume":"4","author":"Bhat","year":"2012","journal-title":"World J Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2025.04.001_bib0023","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2174\/1381612826666200204095401","article-title":"Lifestyle changes for the treatment of nonalcoholic fatty liver disease-A 2015-19 update","volume":"26","author":"Petroni","year":"2020","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.dld.2025.04.001_bib0024","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/1756283X16638830","article-title":"Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials","volume":"9","author":"Zelber-Sagi","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.001_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.921415","article-title":"Dietary acid load (DAL), glycated hemoglobin A1c (HbA1c), and metabolic syndrome (MeS) mediate the association of the adherence to the dietary approaches to stopping hypertension (DASH) and mediterranean diet (MeD) with nonalcoholic fatty liver disease","volume":"9","author":"Doustmohammadian","year":"2022","journal-title":"Front Nutr"},{"issue":"4","key":"10.1016\/j.dld.2025.04.001_bib0026","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1756283X13484078","article-title":"Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial","volume":"6","author":"Eckard","year":"2013","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.dld.2025.04.001_bib0027","article-title":"A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes","volume":"9","author":"Doustmohammadian","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.dld.2025.04.001_bib0028","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.dld.2025.04.001_bib0029","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3390\/nu11122878","article-title":"Dietary patterns and components in nonalcoholic fatty liver disease (NAFLD): what key messages can health care providers offer?","volume":"11","author":"Riazi","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70181-4","article-title":"Path analysis model to identify the effect of poor diet quality on NAFLD among Iranian adults from Amol Cohort Study","volume":"14","author":"Doustmohammadian","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.dld.2025.04.001_bib0031","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41430-022-01240-0","article-title":"Mediators of dietary diversity score (DDS) on NAFLD in Iranian adults: a structural equation modeling study","volume":"77","author":"Doustmohammadian","year":"2023","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.1016\/j.dld.2025.04.001_bib0032","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2007.09.009","article-title":"Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study","volume":"48","author":"Allard","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2025.04.001_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12937-016-0191-8","article-title":"Role of bioactive fatty acids in nonalcoholic fatty liver disease","volume":"15","author":"Ju\u00e1rez-Hern\u00e1ndez","year":"2015","journal-title":"Nutr J"},{"issue":"9","key":"10.1016\/j.dld.2025.04.001_bib0034","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jnutbio.2007.10.001","article-title":"The role of fatty acids in the development and progression of nonalcoholic fatty liver disease","volume":"19","author":"Gentile","year":"2008","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.dld.2025.04.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms","volume":"330","author":"Lian","year":"2020","journal-title":"Chem Biol Interact"},{"issue":"4\u20136","key":"10.1016\/j.dld.2025.04.001_bib0036","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.plefa.2010.02.012","article-title":"Fatty liver: role of inflammation and fatty acid nutrition","volume":"82","author":"Byrne","year":"2010","journal-title":"Prostaglandins, Leukotrienes Essential Fatty Acids (PLEFA)"},{"issue":"11","key":"10.1016\/j.dld.2025.04.001_bib0037","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1039\/c1fo10133a","article-title":"The importance of the long-chain polyunsaturated fatty acid n-6\/n-3 ratio in development of non-alcoholic fatty liver associated with obesity","volume":"2","author":"Valenzuela","year":"2011","journal-title":"Food Funct"},{"issue":"11","key":"10.1016\/j.dld.2025.04.001_bib0038","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4239\/wjd.v2.i11.176","article-title":"A defect in the activities of \u03946 and \u03945 desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease","volume":"2","author":"Das","year":"2011","journal-title":"World J Diabetes"},{"issue":"2","key":"10.1016\/j.dld.2025.04.001_bib0039","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.plipres.2007.12.002","article-title":"Bioactive lipids in metabolic syndrome","volume":"47","author":"Nagao","year":"2008","journal-title":"Prog Lipid Res"},{"issue":"9","key":"10.1016\/j.dld.2025.04.001_bib0040","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1074\/jbc.M807616200","article-title":"Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase","volume":"284","author":"Li","year":"2009","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.dld.2025.04.001_bib0041","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1074\/jbc.M510660200","article-title":"Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis","volume":"281","author":"Malhi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2025.04.001_bib0042","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11010-007-9461-2","article-title":"Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells","volume":"303","author":"Wei","year":"2007","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"10.1016\/j.dld.2025.04.001_bib0043","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dld.2025.04.001_bib0044","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc National Acad Sci"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","article-title":"Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease","volume":"33","author":"Scorletti","year":"2013","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.dld.2025.04.001_bib0046","article-title":"The application of medium-chain fatty acids: edible oil with a suppressing effect on body fat accumulation","volume":"17","author":"Takeuchi","year":"2008","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.dld.2025.04.001_bib0047","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.neurobiolaging.2014.03.038","article-title":"Dietary fat composition and dementia risk","volume":"35","author":"Morris","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.dld.2025.04.001_bib0048","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","article-title":"Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake","volume":"47","author":"Hodson","year":"2008","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.dld.2025.04.001_bib0049","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJM197708182970707","article-title":"Abnormalities of cell-membrane fluidity in the pathogenesis of disease","volume":"297","author":"Ra","year":"1977","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.dld.2025.04.001_bib0050","first-page":"1461","article-title":"Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol","volume":"8","year":"2010","journal-title":"EFSa J"},{"issue":"3","key":"10.1016\/j.dld.2025.04.001_bib0051","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1017\/S0007114512005272","article-title":"A novel fatty acid lipophilic index and risk of CHD in US men: the health professionals follow-up study","volume":"110","author":"Wu","year":"2013","journal-title":"Br J Nutr"},{"issue":"7","key":"10.1016\/j.dld.2025.04.001_bib0052","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3748\/wjg.v20.i7.1746","article-title":"Modulation of hepatic steatosis by dietary fatty acids","volume":"20","author":"Ferramosca","year":"2014","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.dld.2025.04.001_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-020-00638-w","article-title":"Association between a novel dietary lipophilic index (LI) with metabolic phenotypes in a community-based study in Tabriz-Iran","volume":"20","author":"Soltani","year":"2020","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"10.1016\/j.dld.2025.04.001_bib0054","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.numecd.2016.09.006","article-title":"Lipophilic index, kidney function, and kidney function decline","volume":"26","author":"Xu","year":"2016","journal-title":"Nutr, Metabolism Cardiovascular Diseases"},{"issue":"8","key":"10.1016\/j.dld.2025.04.001_bib0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11745-017-4276-8","article-title":"Higher lipophilic index indicates higher risk of coronary heart disease in postmenopausal women","volume":"52","author":"Liu","year":"2017","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0056","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.0000195789.39418.e8","article-title":"Assembly of high-density lipoprotein","volume":"26","author":"Yokoyama","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.dld.2025.04.001_bib0057","first-page":"1012","article-title":"Fatty acids, triglycerides and syndromes of insulin resistance Prostaglandins and plasma lipid and lipoprotein metabolism in human: a critical review","volume":"30","author":"Strolien","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.dld.2025.04.001_bib0058","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.metabol.2004.08.019","article-title":"Dietary trans\u2013fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats","volume":"54","author":"Ibrahim","year":"2005","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0059","first-page":"129","article-title":"Nonalcoholic fatty liver disease as a feature of the metabolic syndrome","volume":"58","author":"Socha","year":"2007","journal-title":"Rocz Panstw Zakl Hig."},{"key":"10.1016\/j.dld.2025.04.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2013.07.003","article-title":"Obesity, insulin resistance, NASH and hepatocellular carcinoma","author":"Yu","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.dld.2025.04.001_bib0061","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0062","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48256-5","article-title":"A prospective cohort study on the association between dietary fatty acids intake and risk of hypertension incident","volume":"13","author":"Shakiba","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2025.04.001_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1329380","article-title":"A population-based prospective study on obesity-related non-communicable diseases in northern Iran: rationale, study design, and baseline analysis","volume":"15","author":"Motamed","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.dld.2025.04.001_bib0064","article-title":"A population based study on hepatitis B virus in northern Iran","volume":"14","author":"Keyvani","year":"2014","journal-title":"Amol Hepatitis Monthly"},{"issue":"11","key":"10.1016\/j.dld.2025.04.001_bib0065","first-page":"0","article-title":"Prevalence and risk factors of cholelithiasis in Amol city, northern Iran: a population based study","volume":"17","author":"Zamani","year":"2014","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.dld.2025.04.001_bib0066","series-title":"Analysing DATA Using SPSS","author":"Garth","year":"2008"},{"issue":"17","key":"10.1016\/j.dld.2025.04.001_bib0067","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/bioinformatics\/bty213","article-title":"LipidPedia: a comprehensive lipid knowledgebase","volume":"34","author":"Kuo","year":"2018","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0068","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cld.1045","article-title":"Nonalcoholic fatty liver disease and recent guideline updates","volume":"17","author":"Ando","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"3","key":"10.1016\/j.dld.2025.04.001_bib0069","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/dme.13565","volume":"35","author":"Sberna","year":"2018","journal-title":"Diabetic Med"},{"key":"10.1016\/j.dld.2025.04.001_bib0070","doi-asserted-by":"crossref","unstructured":"Manual A.P National Health and Nutrition Examination Survey Atlanta, Ga, USA 2007.","DOI":"10.1016\/S0084-3873(08)70164-0"},{"issue":"5","key":"10.1016\/j.dld.2025.04.001_bib0071","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Off J Am College Gastroenterol| ACG"},{"issue":"8","key":"10.1016\/j.dld.2025.04.001_bib0072","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/apt.12038","article-title":"Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study","volume":"36","author":"Gerber","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.04.001_bib0073","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00125-014-3421-7","article-title":"Erythrocyte membrane fatty acid fluidity and risk of type 2 diabetes in the EPIC-Potsdam study","volume":"58","author":"Kr\u00f6ger","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.dld.2025.04.001_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2019.02.001","article-title":"Plasma phospholipid fatty acids are associated with altered fibrin clot properties in a population-based setting","volume":"143","author":"De Lange","year":"2019","journal-title":"Prostaglandins, Leukotrienes Essential Fatty Acids"},{"issue":"9","key":"10.1016\/j.dld.2025.04.001_bib0075","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1194\/jlr.D007534","article-title":"Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions [S]","volume":"51","author":"Matthan","year":"2010","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.dld.2025.04.001_bib0076","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/oby.2006.225","article-title":"Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents","volume":"14","author":"Karlsson","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.dld.2025.04.001_bib0077","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0078","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12944-016-0342-0","article-title":"Revisiting the membrane-centric view of diabetes","volume":"15","author":"Pilon","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.dld.2025.04.001_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-017-0638-z","article-title":"Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection","volume":"16","author":"Russell","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0080","article-title":"Waist-to-height ratio (WHtR) in predicting coronary artery disease compared to body mass index and waist circumference in a single center from Saudi Arabia","volume":"2020","author":"Alshamiri","year":"2020","journal-title":"Cardiol Res Pract"},{"issue":"2","key":"10.1016\/j.dld.2025.04.001_bib0081","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.dld.2025.04.001_bib0082","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","article-title":"Insulin resistance: a metabolic pathway to chronic liver disease","volume":"42","author":"Bugianesi","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0083","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12888-023-05161-5","article-title":"The relationship between dietary lipophilic index and load with depression, anxiety, and stress symptoms","volume":"23","author":"Barzegaran","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.dld.2025.04.001_bib0084","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.bbamem.2017.04.015","article-title":"Membrane lipid alterations in the metabolic syndrome and the role of dietary oils","volume":"1859","author":"Perona","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"issue":"14","key":"10.1016\/j.dld.2025.04.001_bib0085","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.3390\/ijerph17145088","article-title":"Prevalence and predictors of insulin resistance in non-obese healthy young females in Qatar","volume":"17","author":"Elrayess","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.dld.2025.04.001_bib0086","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000415","article-title":"Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort","volume":"5","author":"Owei","year":"2017","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825003123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825003123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T12:31:21Z","timestamp":1752755481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825003123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":86,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1590865825003123"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.04.001","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary lipophilic index and odds of metabolic dysfunction-associated steatotic liver disease (MASLD): A population-based study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}